Cerebral Gray and White Matter Changes and Clinical Course in Metachromatic Leukodystrophy

Overview

Journal Neurology

Specialty Neurology

Date 2012 Sep 21

PMID 22993277

Citations 22

Authors

Samuel Groeschel

Christine I Dali

Philipp Clas

Judith Bohringer

Morten Duno

Christian Krarup

Christiane Kehrer

Marko Wilke

Ingeborg Krageloh-Mann

Affiliations

Soon will be listed here.

Abstract

Objective: Metachromatic leukodystrophy (MLD) is a rare metabolic disorder leading to demyelination and rapid neurologic deterioration. As therapeutic options evolve, it seems essential to understand and quantify progression of the natural disease. The aim of this study was to assess cerebral volumetric changes in children with MLD in comparison to normal controls and in relation to disease course.

Method: Eighteen patients with late-infantile MLD and 42 typically developing children in the same age range (20-59 months) were analyzed in a cross-sectional study. Patients underwent detailed genetic, biochemical, electrophysiologic, and clinical characterization. Cerebral gray matter (GM) and white matter (WM) volumes were assessed by multispectral segmentation of T1- and T2-weighted MRI. In addition, the demyelinated WM (demyelination load) was automatically quantified in T2-weighted images of the patients, and analyzed in relation to the clinical course.

Results: WM volumes of patients did not differ from controls, although their growth curves were slightly different. GM volumes of patients, however, were on average 10.7% (confidence interval 6.0%-14.9%, p < 0.001) below those of normally developing children. The demyelination load (corrected for total WM volume) increased with disease duration (p < 0.003) and motor deterioration (p < 0.001).

Conclusion: GM volume in patients with MLD is reduced when compared with healthy controls, already at young age. This supports the notion that, beside demyelination, neuronal dysfunction caused by neuronal storage plays an additional role in the disease process. The demyelination load may be a useful noninvasive imaging marker for disease progression and may serve as reference for therapeutic intervention.

Citing Articles

The natural history and burden of illness of metachromatic leukodystrophy: a systematic literature review.

Chang S, Eichinger C, Field P Eur J Med Res. 2024; 29(1):181.

PMID: 38494502 PMC: 10946116. DOI: 10.1186/s40001-024-01771-1.

Utilizing hiPSC-derived oligodendrocytes to study myelin pathophysiology in neuropsychiatric and neurodegenerative disorders.

Shim G, Romero-Morales A, Sripathy S, Maher B Front Cell Neurosci. 2024; 17:1322813.

PMID: 38273973 PMC: 10808804. DOI: 10.3389/fncel.2023.1322813.

Effects of sulfatide on peripheral nerves in metachromatic leukodystrophy.

Farah M, Dali C, Groeschel S, Moldovan M, Whiteman D, Malanga C Ann Clin Transl Neurol. 2023; 11(2):328-341.

PMID: 38146590 PMC: 10863914. DOI: 10.1002/acn3.51954.

Neurodegenerative disease after hematopoietic stem cell transplantation in metachromatic leukodystrophy.

Al-Saady M, Beerepoot S, Plug B, Breur M, Galabova H, Pouwels P Ann Clin Transl Neurol. 2023; 10(7):1146-1159.

PMID: 37212343 PMC: 10351661. DOI: 10.1002/acn3.51796.

Clinical Significance of Diffusion Tensor Imaging in Metachromatic Leukodystrophy.

Amedick L, Martin P, Beschle J, Strolin M, Wilke M, Wolf N Neuropediatrics. 2023; 54(4):244-252.

PMID: 37054976 PMC: 10332944. DOI: 10.1055/a-2073-4178.

References

Dali C, Hanson L, Barton N, Fogh J, Nair N, Lund A . Brain N-acetylaspartate levels correlate with motor function in metachromatic leukodystrophy. Neurology. 2010; 75(21):1896-903. DOI: 10.1212/WNL.0b013e3181feb217. View

Onder E, Sinici I, Sonmez F, Topcu M, Ozkara H . Identification of two novel arylsulfatase A mutations with a polymorphism as a cause of metachromatic leukodystrophy. Neurol Res. 2008; 31(1):60-6. DOI: 10.1179/016164108X323762. View

Regis S, Filocamo M, Stroppiano M, Corsolini F, Caroli F, Gatti R . A 9-bp deletion (2320del9) on the background of the arylsulfatase A pseudodeficiency allele in a metachromatic leukodystrophy patient and in a patient with nonprogressive neurological symptoms. Hum Genet. 1998; 102(1):50-3. DOI: 10.1007/s004390050652. View

Draghia R, Letourneur F, Drugan C, Manicom J, Blanchot C, Kahn A . Metachromatic leukodystrophy: identification of the first deletion in exon 1 and of nine novel point mutations in the arylsulfatase A gene. Hum Mutat. 1997; 9(3):234-42. DOI: 10.1002/(SICI)1098-1004(1997)9:3<234::AID-HUMU4>3.0.CO;2-7. View

van der Voorn J, Pouwels P, Kamphorst W, Powers J, Lammens M, Barkhof F . Histopathologic correlates of radial stripes on MR images in lysosomal storage disorders. AJNR Am J Neuroradiol. 2005; 26(3):442-6. PMC: 7976463. View

Clas P, Groeschel S, Wilke M . A semi-automatic algorithm for determining the demyelination load in metachromatic leukodystrophy. Acad Radiol. 2011; 19(1):26-34. DOI: 10.1016/j.acra.2011.09.008. View

Gieselmann V . Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options. Acta Paediatr. 2008; 97(457):15-21. DOI: 10.1111/j.1651-2227.2008.00648.x. View

Ashburner J, Friston K . Unified segmentation. Neuroimage. 2005; 26(3):839-51. DOI: 10.1016/j.neuroimage.2005.02.018. View

Yushkevich P, Piven J, Hazlett H, Smith R, Ho S, Gee J . User-guided 3D active contour segmentation of anatomical structures: significantly improved efficiency and reliability. Neuroimage. 2006; 31(3):1116-28. DOI: 10.1016/j.neuroimage.2006.01.015. View

10.

Kehrer C, Blumenstock G, Gieselmann V, Krageloh-Mann I . The natural course of gross motor deterioration in metachromatic leukodystrophy. Dev Med Child Neurol. 2011; 53(9):850-855. DOI: 10.1111/j.1469-8749.2011.04028.x. View

11.

Cesani M, Capotondo A, Plati T, Sergi Sergi L, Fumagalli F, Roncarolo M . Characterization of new arylsulfatase A gene mutations reinforces genotype-phenotype correlation in metachromatic leukodystrophy. Hum Mutat. 2009; 30(10):E936-45. DOI: 10.1002/humu.21093. View

12.

Hermann S, Schestag F, Polten A, Kafert S, Penzien J, Zlotogora J . Characterization of four arylsulfatase A missense mutations G86D, Y201C, D255H, and E312D causing metachromatic leukodystrophy. Am J Med Genet. 2000; 91(1):68-73. DOI: 10.1002/(sici)1096-8628(20000306)91:1<68::aid-ajmg13>3.0.co;2-g. View

13.

Black J, Cumings J . INFANTILE METACHROMATIC LEUCODYSTROPHY. J Neurol Neurosurg Psychiatry. 2011; 24(3):233-9. PMC: 496699. DOI: 10.1136/jnnp.24.3.233. View

14.

Babalola K, Patenaude B, Aljabar P, Schnabel J, Kennedy D, Crum W . An evaluation of four automatic methods of segmenting the subcortical structures in the brain. Neuroimage. 2009; 47(4):1435-47. DOI: 10.1016/j.neuroimage.2009.05.029. View

15.

Kehrer C, Blumenstock G, Raabe C, Krageloh-Mann I . Development and reliability of a classification system for gross motor function in children with metachromatic leucodystrophy. Dev Med Child Neurol. 2010; 53(2):156-60. DOI: 10.1111/j.1469-8749.2010.03821.x. View

16.

Almli C, Rivkin M, McKinstry R . The NIH MRI study of normal brain development (Objective-2): newborns, infants, toddlers, and preschoolers. Neuroimage. 2007; 35(1):308-25. DOI: 10.1016/j.neuroimage.2006.08.058. View

17.

Eichler F, Grodd W, Grant E, Sessa M, Biffi A, Bley A . Metachromatic leukodystrophy: a scoring system for brain MR imaging observations. AJNR Am J Neuroradiol. 2009; 30(10):1893-7. PMC: 7051299. DOI: 10.3174/ajnr.A1739. View

18.

Colello R, Pott U, Schwab M . The role of oligodendrocytes and myelin on axon maturation in the developing rat retinofugal pathway. J Neurosci. 1994; 14(5 Pt 1):2594-605. PMC: 6577449. View

19.

Peng L, Suzuki K . Ultrastructural study of neurons in metachromatic leukodystrophy. Clin Neuropathol. 1987; 6(5):224-30. View

20.

Lugowska A, Wlodarski P, Ploski R, Mierzewska H, Dudzinska M, Matheisel A . Molecular and clinical consequences of novel mutations in the arylsulfatase A gene. Clin Genet. 2008; 75(1):57-64. DOI: 10.1111/j.1399-0004.2008.01108.x. View